Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olayinka Raheem

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|November 23, 2006
[Not Available]Olayinka Raheem, Tiina Suominen, Peter Hackman, et al.
Journal of Neurology|February 1, 2011
A novel MYH7 mutation occurring independently in French and Norwegian Laing distal myopathy families and de novo in one Finnish patientOdile Dubourg, Thierry Maisonobe, Anthony Behin, et al.
The American Journal of Pathology|June 8, 2014
Abnormal splicing of NEDD4 in myotonic dystrophy type 2: possible link to statin adverse reactionsMark Screen, Per Harald Jonson, Olayinka Raheem, et al.
The American Journal of Pathology|October 26, 2010
Mutant (CCTG)n expansion causes abnormal expression of zinc finger protein 9 (ZNF9) in myotonic dystrophy type 2Olayinka Raheem, Shodimu-Emmanuel Olufemi, Linda L Bachinski, et al.
Neurology|November 16, 2012
New immunohistochemical method for improved myotonia and chloride channel mutation diagnosticsOlayinka Raheem, Sini Penttilä, Tiina Suominen, et al.
The American Journal of Pathology|August 14, 2015
Differential isoform expression and selective muscle involvement in muscular dystrophiesSanna Huovinen, Sini Penttilä, Panu Somervuo, et al.
Cancer Research|September 28, 2016
PP2A Inhibitor PME-1 Drives Kinase Inhibitor Resistance in Glioma CellsAmanpreet Kaur, Oxana V Denisova, Xi Qiao, et al.
Journal of Neurology|March 13, 2012
Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2Rosanna Cardani, Marzia Giagnacovo, Annalisa Botta, et al.
Cancer Research|March 19, 2009
PME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A-mediated inactivation in human malignant gliomaPietri Puustinen, Melissa R Junttila, Sari Vanhatupa, et al.
European Journal of Human Genetics : EJHG|November 7, 2013
Recessive myosin myopathy with external ophthalmoplegia associated with MYH2 mutationsHoma Tajsharghi, Simon Hammans, Christopher Lindberg, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Duodecim; Laaketieteellinen Aikakauskirja|November 23, 2006
[Not Available]Olayinka Raheem, Tiina Suominen, Peter Hackman, et al.
Journal of Neurology|February 1, 2011
A novel MYH7 mutation occurring independently in French and Norwegian Laing distal myopathy families and de novo in one Finnish patientOdile Dubourg, Thierry Maisonobe, Anthony Behin, et al.
The American Journal of Pathology|June 8, 2014
Abnormal splicing of NEDD4 in myotonic dystrophy type 2: possible link to statin adverse reactionsMark Screen, Per Harald Jonson, Olayinka Raheem, et al.
The American Journal of Pathology|October 26, 2010
Mutant (CCTG)n expansion causes abnormal expression of zinc finger protein 9 (ZNF9) in myotonic dystrophy type 2Olayinka Raheem, Shodimu-Emmanuel Olufemi, Linda L Bachinski, et al.
Neurology|November 16, 2012
New immunohistochemical method for improved myotonia and chloride channel mutation diagnosticsOlayinka Raheem, Sini Penttilä, Tiina Suominen, et al.
The American Journal of Pathology|August 14, 2015
Differential isoform expression and selective muscle involvement in muscular dystrophiesSanna Huovinen, Sini Penttilä, Panu Somervuo, et al.
Cancer Research|September 28, 2016
PP2A Inhibitor PME-1 Drives Kinase Inhibitor Resistance in Glioma CellsAmanpreet Kaur, Oxana V Denisova, Xi Qiao, et al.
Journal of Neurology|March 13, 2012
Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2Rosanna Cardani, Marzia Giagnacovo, Annalisa Botta, et al.
Cancer Research|March 19, 2009
PME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A-mediated inactivation in human malignant gliomaPietri Puustinen, Melissa R Junttila, Sari Vanhatupa, et al.
European Journal of Human Genetics : EJHG|November 7, 2013
Recessive myosin myopathy with external ophthalmoplegia associated with MYH2 mutationsHoma Tajsharghi, Simon Hammans, Christopher Lindberg, et al.
Pageof 3